
PRE Stock Forecast & Price Target
PRE Analyst Ratings
Bulls say
Prenetics Global is well-positioned in a rapidly growing subset of the global dietary supplements market, with strong clinical validation, an attractive value proposition, and a successful track record of customer acquisition, retention, and monetization. The company's expanding product portfolio, growing roster of influential brand ambassadors, and strategic marketing initiatives make it a high-growth potential company with a positive revenue CAGR outlook. Additionally, Prenetics has a strong balance sheet and experienced leadership, providing a solid foundation for sustainable growth and potential profitability.
Bears say
Prenetics Global is experiencing strong financial improvement due to the introduction and expansion of quarterly subscription plans, resulting in higher average order value, improved customer subscription rates, higher revenue, and improved LTV/CAC. This shift to quarterly subscriptions is also leading to lower fulfillment costs and more predictable renewals, creating a positive impact on the company's financial health and reducing its working capital demands.
This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.
PRE Analyst Forecast & Price Prediction
Start investing in PRE
Order type
Buy in
Order amount
Est. shares
0 shares